A detailed history of Canada Pension Plan Investment Board transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 600 shares of KRYS stock, worth $123,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 1,000 40.0%
Holding current value
$123,696
Previous $137,000 23.36%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$134.94 - $176.75 $53,976 - $70,700
-400 Reduced 40.0%
600 $105,000
Q2 2025

Aug 14, 2025

SELL
$123.36 - $181.0 $37,008 - $54,300
-300 Reduced 23.08%
1,000 $137,000
Q1 2025

May 14, 2025

BUY
$142.64 - $194.44 $185,431 - $252,772
1,300 New
1,300 $234,000

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $5.29B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.